MedPath

Clinical Study in Post-operation Treatment of Cervical Cancer

Conditions
Cervical Cancer
Registration Number
NCT01418859
Lead Sponsor
Health Science Center of Xi'an Jiaotong University
Brief Summary

The purpose of the research is to evaluate the effect of additional chemotherapy in postoperation therapy of cervical cancer patients with risk factors (big tumor, deep invasion or tumor thrombi in the vascular system).

Detailed Description

Cervical cancer has a very high morbidity. Many patients need additional therapy after surgery in order to elevate the survival rate and life quality. In this research, we are going to give additional therapy to patients who have big tumor, deep invasion or tumor thrombi in the vascular system after surgery. randomized control method will be used in this research, in order to compare the survival rate and side effects between radiation therapy only, concurrent chemoradiotherapy, and concurrent chemoradiotherapy with additional chemotherapy. 3D-CRT and Topotecan will be used in this research.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
183
Inclusion Criteria
  1. patients who underwent the cervical cancer radical surgery in three months have higt risk factors which including deep stromal invasion,large primary tumour and/or lymphovascular spase invasion;
  2. squamous carcinoma;
  3. age<70;
  4. Gynecologic Oncology Group (GOG):0-2.
Exclusion Criteria
  1. negative nodes,surgical margin,and/or parametrium;
  2. No serious damage to the liver and kidney function, no hypertension,diabetes and other effects of therapy complications.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xi'an Jiaotong University College of Medicine

🇨🇳

Xi'an, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath